23 Feb SAHPRA Responds to Carte Blanche Report on Alleged GMP Non-compliance at Adcock Ingram Clayville Facility
Pretoria, 23 February 2026 – The South African Health Products Regulatory Authority (SAHPRA) has noted the recent Carte Blanche broadcast raising concerns, based on information from a former employee, regarding alleged Good Manufacturing Practice (GMP) non-compliance at Adcock Ingram’s manufacturing facility in Clayville, Johannesburg. SAHPRA wishes...